Skip to main content
Premium Trial:

Request an Annual Quote

Manchester University Wins $11.5M Grant to Open Systems Biology Center

NEW YORK, March 14 (GenomeWeb News) - The University of Manchester, UK, has won a £6 million ($11.5 million) government grant to open a new systems biology center, the school said today.

The new facility, called the Manchester Centre for Integrative Systems Biology, will use this money "to develop new methods of computational and mathematical analysis, validating these methods by testing them in yeast."


These methods will then be used to "create generic computational models with the potential to allow pharmaceutical companies to perform virtual trials of any medicine on any living organism," the university said.

The award was provided by The Biotechnology and Biological Sciences Research Council.


"Our aim is to develop the systems which will allow University scientists and pharmaceutical companies to understand how every gene in an organism works and reacts," said Douglas Kell, director of the new center. "This will provide them with the tools they need to develop safer and more effective medicines and will put Manchester on the map as one of the world centers for systems biology research."


It was not immediately clear when the new center will open.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.